documents: FDA-2017-N-6313-0002

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2017-N-6313-0002 FDA FDA-2017-N-6313 Prescription Drug User Fee Act VI Commitment to Assess Current Practices of the Food and Drug Administration and Sponsors in Communicating During Investigational New Drug Development; Establishment of a Public Docket; Request for Comments Other Assessment Document or Analysis 2017-12-08T05:00:00Z 2017 12 2017-12-08T05:00:00Z   2018-01-24T17:30:42Z   0 0 0900006482cf38d4

Links from other tables